Literature DB >> 23879537

Vitamin D and microRNAs in bone.

Thomas S Lisse1, John S Adams, Martin Hewison.   

Abstract

MicroRNAs (miRNAs) are short noncoding RNAs that orchestrate complex posttranscriptional regulatory networks essential to the regulation of gene expression. Through complementarity with messenger RNA (mRNA) sequences, miRNAs act primarily to silence gene expression through either degradation or inhibited translation of target transcripts. In this way, miRNAs can act to fine-tune the transcriptional regulation of gene expression, but they may also play distinct roles in the proliferation, differentiation, and function of specific cell types. miRNA regulatory networks may be particularly important for signaling molecules such as vitamin D that exert pleiotropic effects on tissues throughout the body. The active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D) functions as a steroid hormone that, when bound to its nuclear vitamin D receptor, is able to regulate target gene expression. However, recent studies have also implicated 1,25(OH)2D in epigenetic regulation of genes most notably as a modulator of miRNA function. The current review details our understanding of vitamin D and miRNAs with specific emphasis on the implications of this interaction for biological responses to vitamin D in one of its classical target tissues, i.e., bone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23879537      PMCID: PMC3857713          DOI: 10.1615/critreveukaryotgeneexpr.2013007147

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  143 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

2.  MicroRNAs, macrocontrol: regulation of miRNA processing.

Authors:  Izabella Slezak-Prochazka; Selvi Durmus; Bart-Jan Kroesen; Anke van den Berg
Journal:  RNA       Date:  2010-04-27       Impact factor: 4.942

3.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

Review 4.  New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites.

Authors:  Isidore Rigoutsos
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 5.  Vitamin D and innate and adaptive immunity.

Authors:  Martin Hewison
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

Review 6.  Antibacterial effects of vitamin D.

Authors:  Martin Hewison
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

7.  Steroidal regulation of uterine miRNAs is associated with modulation of the miRNA biogenesis components Exportin-5 and Dicer1.

Authors:  Warren B Nothnick; Caitlin Healy; Xiaoman Hong
Journal:  Endocrine       Date:  2010-04       Impact factor: 3.633

Review 8.  Molecular mechanisms of vitamin D action.

Authors:  Mark R Haussler; G Kerr Whitfield; Ichiro Kaneko; Carol A Haussler; David Hsieh; Jui-Cheng Hsieh; Peter W Jurutka
Journal:  Calcif Tissue Int       Date:  2012-07-11       Impact factor: 4.333

9.  MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7.

Authors:  Shireen Kahai; Shao-Chen Lee; Daniel Y Lee; Jennifer Yang; Minhui Li; Chia-Hui Wang; Zide Jiang; Yaou Zhang; Chun Peng; Burton B Yang
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

10.  MicroRNA regulates human vitamin D receptor.

Authors:  Takuya Mohri; Miki Nakajima; Shingo Takagi; Sayaka Komagata; Tsuyoshi Yokoi
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

View more
  18 in total

Review 1.  Non-coding RNAs: Epigenetic regulators of bone development and homeostasis.

Authors:  Mohammad Q Hassan; Coralee E Tye; Gary S Stein; Jane B Lian
Journal:  Bone       Date:  2015-05-31       Impact factor: 4.398

2.  MicroRNA-351 promotes schistosomiasis-induced hepatic fibrosis by targeting the vitamin D receptor.

Authors:  Xing He; Yue Sun; Nanhang Lei; Xiaobin Fan; Cheng Zhang; Yange Wang; Kuiyang Zheng; Dongmei Zhang; Weiqing Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-18       Impact factor: 11.205

Review 3.  Multiple levels of epigenetic control for bone biology and pathology.

Authors:  Martin Montecino; Gary Stein; Janet Stein; Kaleem Zaidi; Rodrigo Aguilar
Journal:  Bone       Date:  2015-04-10       Impact factor: 4.398

Review 4.  The role of nuclear hormone receptors in cutaneous wound repair.

Authors:  Sandra Rieger; Hengguang Zhao; Paige Martin; Koichiro Abe; Thomas S Lisse
Journal:  Cell Biochem Funct       Date:  2014-12-22       Impact factor: 3.685

Review 5.  Vitamin D and alternative splicing of RNA.

Authors:  Rui Zhou; Rene F Chun; Thomas S Lisse; Alejandro J Garcia; Jianzhong Xu; John S Adams; Martin Hewison
Journal:  J Steroid Biochem Mol Biol       Date:  2014-10-16       Impact factor: 4.292

Review 6.  Circulating miRNAs as biomarkers for endocrine disorders.

Authors:  H Butz; N Kinga; K Racz; A Patocs
Journal:  J Endocrinol Invest       Date:  2015-05-28       Impact factor: 4.256

7.  Vitamin D Status, Cardiovascular Risk Profile, and miRNA-21 Levels in Hypertensive Patients: Results of the HYPODD Study.

Authors:  Domenico Rendina; Lanfranco D Elia; Veronica Abate; Andrea Rebellato; Ilaria Buondonno; Mariangela Succoio; Fabio Martinelli; Riccardo Muscariello; Gianpaolo De Filippo; Patrizia D Amelio; Francesco Fallo; Pasquale Strazzullo; Raffaella Faraonio
Journal:  Nutrients       Date:  2022-06-28       Impact factor: 6.706

Review 8.  Modeling vitamin D actions in triple negative/basal-like breast cancer.

Authors:  Erika LaPorta; JoEllen Welsh
Journal:  J Steroid Biochem Mol Biol       Date:  2013-11-14       Impact factor: 4.292

9.  Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis.

Authors:  A Sakai; M Ito; T Tomomitsu; H Tsurukami; S Ikeda; F Fukuda; H Mizunuma; T Inoue; H Saito; T Nakamura
Journal:  Osteoporos Int       Date:  2015-01-16       Impact factor: 4.507

10.  Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cells.

Authors:  Heidrun Karlic; Roman Thaler; Christopher Gerner; Thomas Grunt; Katharina Proestling; Florian Haider; Franz Varga
Journal:  Cancer Genet       Date:  2015-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.